CONVICT: sentencing Cancer cells to death through ONcolytic Virotherapy and modulation of the Immune Checkpoint TIGIT

Zeven, Katty (Administrative Promotor)
Devoogdt, Nick (Administrative Promotor)

Supporting clinical sciences

2 Poster
1 Unpublished abstract
1 Article

4 results

2024
Noninvasive nuclear imaging of the immune checkpoint TIGIT using different nanobody-scaffolds and radionuclides
Zeven, K., Dierick, H., Sevenois, M., Baudhuin, H. V., Bridoux, J., Navarro, L., De Groof, T., Raes, G., Breckpot, K. & Devoogdt, N., 13 Mar 2024, (Unpublished).
Research output: Unpublished contribution to conference › Poster
The development of Nanobodies against the next-generation immune checkpoint TIGIT with diagnostic and therapeutic potential
Zeven, K., De Groof, T., Raes, G., Breckpot, K. & Devoogdt, N., 18 Apr 2024, (Unpublished).
Research output: Unpublished contribution to conference › Poster
2023
The development of radiolabeled nanobodies against the next-generation immune checkpoint TIGIT for non-invasive immune phenotyping of tumors
Zeven, K., De Groof, T., Awad, R. M., De Mey, W., Ertveldt, T., Ceuppens, H., De Jonghe, K., Raes, G., Keyaerts, M., Breckpot, K. & Devoogdt, N., 2023.
Research output: Unpublished contribution to conference › Unpublished abstract
2021
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer
Lecocq, Q., Debie, P., Puttemans, J., Awad, R. M., De Beck, L., Ertveldt, T., De Vlaeminck, Y., Goyvaerts, C., Raes, G., Keyaerts, M., Breckpot, K. & Devoogdt, N., 2 Nov 2021, In: EJNMMI Research. 11, 1, 13 p., 115.
Research output: Contribution to journal › Article › peer-review

Open Access
File
4 Citations (Scopus)

124 Downloads (Pure)